Iradimed (IRMD) Gross Profit (2013 - 2026)

Iradimed (IRMD) has reported Gross Profit for 14 consecutive years, with $15.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Profit fell 4.98% year-over-year to $15.2 million in Q2 2026; TTM through Jun 2026 was $65.5 million, a 9.62% increase from a year earlier, with the FY2025 full-year figure at $64.3 million, up 14.15% from the prior year.
• Gross Profit was $15.2 million for Q2 2026 at Iradimed, down from $16.8 million in the prior quarter.
• Over five years, Gross Profit peaked at $17.0 million in Q4 2025 and troughed at $9.4 million in Q1 2022.
• A 5-year average of $13.6 million and a median of $13.7 million in 2023 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit jumped 38.29% in 2022 and slipped 4.98% in 2026, its largest moves.
• Over 5 years, Gross Profit stood at $11.2 million in 2022, then grew by 19.54% to $13.4 million in 2023, then increased by 10.05% to $14.8 million in 2024, then increased by 15.38% to $17.0 million in 2025, then declined by 10.99% to $15.2 million in 2026.
• The last three Gross Profit figures came in at $15.2 million (Q2 2026), $16.8 million (Q1 2026), and $17.0 million (Q4 2025), per Business Quant data.